GPR40 (FFAR1) Human shRNA Plasmid Kit (Locus ID 2864)
CAT#: TR313001
FFAR1 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 4,790.00
货期*
现货
规格
Cited in 5 publications. |
Product images
经常一起买 (2)
Specifications
Product Data | |
Product Name | GPR40 (FFAR1) Human shRNA Plasmid Kit (Locus ID 2864) |
Locus ID | 2864 |
UniProt ID | O14842 |
Synonyms | FFA1R; GPCR40; GPR40 |
Vector | pRS |
Format | Retroviral plasmids |
Kit Components | FFAR1 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector(Gene ID = 2864). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pRS Vector, TR30012, included for free. |
RefSeq | NM_005303, NM_005303.1, NM_005303.2, BC039436, BC095536, BC120943, BC120944 |
Summary | This gene encodes a member of the GP40 family of G protein-coupled receptors that are clustered together on chromosome 19. The encoded protein is a receptor for medium and long chain free fatty acids and may be involved in the metabolic regulation of insulin secretion. Polymorphisms in this gene may be associated with type 2 diabetes. [provided by RefSeq, Apr 2009] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (5)
The use of this RNAi has been cited in the following citations: |
---|
Regulation of cell survival through free fatty acid receptor 1 (FFA1) and FFA4 induced by endothelial cells in osteosarcoma cells
,Minami, K;Ueda, N;Ishimoto, K;Tsujiuchi, T;,
J. Recept. Signal Transduct. Res.
,PubMed ID 32026734
[FFAR1]
|
Induction of GPR40 positively regulates cell motile and growth activities in breast cancer MCF-7 cells
,Fukushima, K;Takahashi, K;Kusaka, M;Ishimoto, K;Minami, K;Otagaki, S;Fukushima, N;Honoki, K;Tsujiuchi, T;,
J. Recept. Signal Transduct. Res.
,PubMed ID 30111226
[FFAR1]
|
Diverse effects of G-protein-coupled free fatty acid receptors on the regulation of cellular functions in lung cancer cells
,Kita, T;Kadochi, Y;Takahashi, K;Fukushima, K;Yamasaki, E;Uemoto, T;Hirane, M;Fukushima, N;Honoki, K;Tsujiuchi, T;,
Exp. Cell Res.
,PubMed ID 26968637
[FFAR1]
|
Negative effects of G-protein-coupled free fatty acid receptor GPR40 on cell migration and invasion in fibrosarcoma HT1080 cells
,Ishii, S;Kitamura, Y;Hirane, M;Tomimatsu, A;Fukushima, K;Takahashi, K;Fukushima, N;Honoki, K;Tsujiuchi, T;,
Mol. Carcinog.
,PubMed ID 26331585
[FFAR1]
|
Different roles of GPR120 and GPR40 in the acquisition of malignant properties in pancreatic cancer cells
,Fukushima, K;Yamasaki, E;Ishii, S;Tomimatsu, A;Takahashi, K;Hirane, M;Fukushima, N;Honoki, K;Tsujiuchi, T;,
Biochem. Biophys. Res. Commun.
,PubMed ID 26282200
[FFAR1]
|
Documents
Product Manuals |
FAQs |
SDS |
Customer
Reviews
Loading...